AKT1 and ovarian carcinoma: A single amino acid substitution, E17K, in the lipid-binding PH domain of AKT-1 is a recurrent somatic cell mutation that occurs in breast cancer, meningioma, colorectal, endometrial, and ovarian cancers, and the mutation results in constitutive AKT1 activation [108,109].